Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697187 | Brachytherapy | 2017 | 12 Pages |
Abstract
Due to a series of technological advances, modern combination series have demonstrated unparalleled rates of disease control in the high-risk population. Given the evidence from recent randomized trials, combination therapy may become the standard of care for high-risk cancers.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Daniel E. Spratt, Payal D. Soni, Patrick W. McLaughlin, Gregory S. Merrick, Richard G. Stock, John C. Blasko, Michael J. Zelefsky,